Stricter Blood Pressure Control Is Associated With Lower Left Ventricular Mass in Children After Kidney Transplantation: A Longitudinal Analysis of the 4C-T Study

Küçük Resim Yok

Tarih

2023

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Lippincott Williams and Wilkins

Erişim Hakkı

info:eu-repo/semantics/openAccess

Özet

BACKGROUND: We assessed the effect of blood pressure (BP) control on left ventricular mass index (LVMI) and left ventricular hypertrophy (LVH). METHODS: Ninety-six patients (64 males) ?9 months post-kidney transplantation from the 4C-T (Cardiovascular Comorbidity in Children with Chronic Kidney Disease and Transplantation) study were analyzed longitudinally (mean follow-up, 2.6±1.3 years). Cumulative systolic blood pressure (SBP)/diastolic BP exposure was calculated as a time-averaged area under the curve and categorized: ?50th, 50th to ?75th, 75th to ?90th, and >90th percentile (pct). We performed adjusted linear and logistic mixed models for LVMI and LVH, respectively. RESULTS: At baseline, LVMI was 49.7±12.7g/m2.16 with 64% (n=61) kidney transplantation recipients displaying LVH. Compared with patients with cumulative SBP exposure >90th pct, patients with cumulative SBP of 50th to ?75th showed a significant LVMI reduction of -5.24g/m2.16 (P=0.007). A similar tendency was seen for cumulative SBP?50th (?=-3.70 g/m2.16; P=0.067), but patients with cumulative SBP of 75th to ?90th pct showed no reduction. A post hoc analysis in patients with cumulative SBP?75th revealed that median SBP exposure was at 57.5th pct. For cumulative diastolic BP, a significant LVMI reduction was seen in all 3 categories ?90th pct compared with patients >90th pct. Patients with cumulative SBP of ?50th or 50th to ?75th pct showed 79% or 83% lower odds of developing LVH, respectively. Patients with cumulative diastolic BP ?50th showed a tendency of 82% lower odds for LVH (95% CI, 0.03-1.07). CONCLUSIONS: Stricter BP control led to regression of LVMI and LVH. Our data suggest a BP target below the 60th pct, which needs to be substantiated in a randomized controlled trial. © 2023 Lippincott Williams and Wilkins. All rights reserved.

Açıklama

Anahtar Kelimeler

cardiovascular disease, hypertension, hypertrophy, left ventricular, pediatric nephrology, prospective study, antihypertensive agent, cyclosporine, everolimus, sirolimus, steroid, tacrolimus, adolescent, antihypertensive therapy, Article, blood pressure regulation, body mass, child, cohort analysis, controlled study, diastolic blood pressure, echocardiography, estimated glomerular filtration rate, female, follow up, graft recipient, heart left ventricle mass, human, human tissue, hypertension, kidney transplantation, left ventricular end-diastolic diameter, left ventricular hypertrophy, left ventricular mass index, major clinical study, male, pediatric surgery, post hoc analysis, randomized controlled trial, renin angiotensin aldosterone system, systolic blood pressure, blood pressure, chronic kidney failure, comorbidity, complication, hypertension, left ventricular hypertrophy, physiology, Blood Pressure, Child, Comorbidity, Humans, Hypertension, Hypertrophy, Left Ventricular, Kidney Transplantation, Male, Renal Insufficiency, Chronic

Kaynak

Hypertension

WoS Q Değeri

Scopus Q Değeri

Q1

Cilt

80

Sayı

9

Künye